top of page
![](https://static.wixstatic.com/media/3c2eca45c90b483b9386d2b7eef92ae2.jpg/v1/fill/w_45,h_30,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/3c2eca45c90b483b9386d2b7eef92ae2.jpg)
Docteur Joseph MONSONEGO
Gynécologie - Colposcopie
Pathologies génitales à papillomavirus
![INSTITUT_DU_COL_edited.jpg](https://static.wixstatic.com/media/47895b_5b7774f6b40343fb8ac9f6ec7d31ed4a~mv2.jpg/v1/fill/w_114,h_83,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/INSTITUT_DU_COL_edited.jpg)
Actualités
Vaccination HPV
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancerin 181 countries, 2020-99 : a modelling study
www.thelancet.com - Published online February 19, 2019
Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017±2035: Example from Australia
PLOS ONE | https://doi.org/10.1371/journal.pone.0185332 February 14, 2018
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
www.thelancet.com - Published online September 5, 2017
Nine-valent human papillomavirus vaccine: great science, but will it save lives?
www.thelancet.com - Published online September 5, 2017
bottom of page